EG18956A - Antiparasitic formulations - Google Patents
Antiparasitic formulationsInfo
- Publication number
- EG18956A EG18956A EG22590A EG22590A EG18956A EG 18956 A EG18956 A EG 18956A EG 22590 A EG22590 A EG 22590A EG 22590 A EG22590 A EG 22590A EG 18956 A EG18956 A EG 18956A
- Authority
- EG
- Egypt
- Prior art keywords
- antiparasitic formulations
- antiparasitic
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898908071A GB8908071D0 (en) | 1989-04-11 | 1989-04-11 | Antiparasitic formulations |
SG27894A SG27894G (en) | 1989-04-11 | 1994-02-22 | Injectable compositions containing 25-cyclohexyl-avermectin B1 |
Publications (1)
Publication Number | Publication Date |
---|---|
EG18956A true EG18956A (en) | 1994-04-30 |
Family
ID=26295191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EG22590A EG18956A (en) | 1989-04-11 | 1990-04-11 | Antiparasitic formulations |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0393890B1 (zh) |
JP (1) | JPH0647548B2 (zh) |
CN (1) | CN1035356C (zh) |
AP (1) | AP133A (zh) |
AU (1) | AU609660B2 (zh) |
CY (1) | CY1777A (zh) |
DK (1) | DK0393890T3 (zh) |
EG (1) | EG18956A (zh) |
ES (1) | ES2052173T3 (zh) |
FI (1) | FI92015C (zh) |
GR (1) | GR3005794T3 (zh) |
HK (1) | HK39294A (zh) |
NO (1) | NO175882C (zh) |
OA (1) | OA09203A (zh) |
RU (1) | RU1836084C (zh) |
SG (1) | SG27894G (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19613972A1 (de) * | 1996-04-09 | 1997-10-16 | Bayer Ag | Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl |
EP0928136B1 (en) * | 1996-06-05 | 2003-10-22 | Ashmont Holdings Limited | Injectable compositions |
DE19638045A1 (de) * | 1996-09-18 | 1998-03-19 | Bayer Ag | Injektionsformulierungen von Avermectinen und Milbemycinen |
KR20000025762A (ko) * | 1998-10-14 | 2000-05-06 | 유충식 | 이버멕틴류의 가용화 조성물 |
GB9827727D0 (en) | 1998-12-16 | 1999-02-10 | Pfizer Ltd | Antiparasitic formulations |
NZ590141A (en) * | 2008-06-24 | 2012-05-25 | Merial Ltd | Anthelminthic formulations including castor oil and another vegetable oil |
CA2750626C (en) * | 2009-02-16 | 2013-10-01 | Pfizer Inc. | High dosage doramectin formulation |
WO2011043962A2 (en) * | 2009-10-07 | 2011-04-14 | Wyeth Llc | Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1182857B (it) * | 1984-09-14 | 1987-10-05 | Glaxo Group Ltd | Composti antibiotici, composizioni antiparassitarie che li contengono e procedimento per prepararli ed applicarli |
ES8802229A1 (es) * | 1985-04-30 | 1988-04-16 | Glaxo Group Ltd | Un procedimiento para preparar nuevos derivados lactonicos macrociclicos. |
US4707470A (en) * | 1985-05-17 | 1987-11-17 | Smithkline Beckman Corporation | Polyene antibiotic emulsion formulation |
EP0285561A3 (de) * | 1987-03-27 | 1989-10-25 | Ciba-Geigy Ag | Parasitizide und insektizide Milbemycin-Derivate |
ATE87926T1 (de) * | 1987-11-09 | 1993-04-15 | Pfizer | Ethylierte avermectine. |
-
1990
- 1990-04-06 EP EP90303716A patent/EP0393890B1/en not_active Expired - Lifetime
- 1990-04-06 ES ES90303716T patent/ES2052173T3/es not_active Expired - Lifetime
- 1990-04-06 DK DK90303716.6T patent/DK0393890T3/da active
- 1990-04-09 AP APAP/P/1990/000174A patent/AP133A/en active
- 1990-04-10 FI FI901816A patent/FI92015C/fi active IP Right Grant
- 1990-04-10 RU SU904743681A patent/RU1836084C/ru active
- 1990-04-10 AU AU53119/90A patent/AU609660B2/en not_active Ceased
- 1990-04-10 NO NO901637A patent/NO175882C/no not_active IP Right Cessation
- 1990-04-10 OA OA59772A patent/OA09203A/xx unknown
- 1990-04-11 JP JP2096150A patent/JPH0647548B2/ja not_active Expired - Fee Related
- 1990-04-11 EG EG22590A patent/EG18956A/xx active
- 1990-04-11 CN CN90102072A patent/CN1035356C/zh not_active Expired - Lifetime
-
1992
- 1992-09-24 GR GR920402116T patent/GR3005794T3/el unknown
-
1994
- 1994-02-22 SG SG27894A patent/SG27894G/en unknown
- 1994-04-28 HK HK39294A patent/HK39294A/xx not_active IP Right Cessation
-
1995
- 1995-10-20 CY CY177795A patent/CY1777A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
FI92015C (fi) | 1994-09-26 |
RU1836084C (ru) | 1993-08-23 |
FI901816A0 (fi) | 1990-04-10 |
CN1035356C (zh) | 1997-07-09 |
SG27894G (en) | 1995-03-17 |
FI92015B (fi) | 1994-06-15 |
NO175882C (no) | 1994-12-28 |
CY1777A (en) | 1995-10-20 |
NO175882B (no) | 1994-09-19 |
DK0393890T3 (da) | 1992-09-28 |
EP0393890A1 (en) | 1990-10-24 |
AU5311990A (en) | 1990-11-08 |
AP9000174A0 (en) | 1990-04-30 |
ES2052173T3 (es) | 1994-07-01 |
JPH02290820A (ja) | 1990-11-30 |
JPH0647548B2 (ja) | 1994-06-22 |
AP133A (en) | 1991-06-05 |
OA09203A (fr) | 1992-06-30 |
GR3005794T3 (zh) | 1993-06-07 |
NO901637D0 (no) | 1990-04-10 |
HK39294A (en) | 1994-05-06 |
CN1046282A (zh) | 1990-10-24 |
EP0393890B1 (en) | 1992-08-12 |
NO901637L (no) | 1990-10-12 |
AU609660B2 (en) | 1991-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8925876D0 (en) | Marker | |
GB8908250D0 (en) | Formulations | |
EP0413610A3 (en) | Pesticidal formulations | |
GB8815967D0 (en) | Antiparasitic agents | |
EG18956A (en) | Antiparasitic formulations | |
EP0433909A3 (en) | Formulation | |
GB8914791D0 (en) | Formulation | |
EP0416374A3 (en) | Cultivator | |
ZA902737B (en) | Antiparasitic formulations | |
GB8924207D0 (en) | Formulations | |
GB8922917D0 (en) | Formulations | |
GB8922288D0 (en) | Formulations | |
GB8914790D0 (en) | Formulations | |
GB8905015D0 (en) | Formulations | |
GB8908249D0 (en) | Formulations | |
GB8924635D0 (en) | Formulations | |
IE894052L (en) | Formulations | |
GB8926129D0 (en) | Formulations | |
IE890604L (en) | Antiparasitic agents | |
ZA906538B (en) | Pesticidal formulations | |
GB8922061D0 (en) | Controlled release formulations | |
CS401289A1 (en) | Levelling-and-migrating preparation | |
GB8908900D0 (en) | Tree-base stable | |
GB8911554D0 (en) | Formulation | |
GB8926629D0 (en) | Formulation |